Skip to Content

Significantly improved pathological complete response with nivolumab + chemotherapy in NSCLC

Jonathan Spicer, Assistant Professor of Surgery, McGill University, Montreal General Hospital, presents in this MEDtalk the results from CheckMate 816, a randomized phase 3 study of neoadjuvant NIVO + chemo vs chemo in resectable NSCLC.

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top